Email this article to a Colleague Similar articles in this journal Alert me to new issues of the journal Download to citation manager

Preliminary Program: Wednesday, May 7

Industry-Supported Breakfast Symposia
 

7:30 a.m.-5 p.m.

Registration/Course Enrollment Open
 

8 a.m.-Noon

CME Courses 79-82
 

8 a.m.-5 p.m.

CME Course 83
 

9 a.m.-10:30 a.m.

Case Conference 3 Charles Nemeroff, M.D., on Psychopharmacology (Open to APA members only)

Lectures

L22. Dan G. Blazer, M.D., Oskar Pfister Award Lecture

L23. Maria Oquendo, M.D., Distinguished Psychiatrist Lecture

Small Interactive Sessions

13. Robert Findling, M.D., on Child and Adolescent Psychopharmacology (Meet the Author)

14. Fred Goodwin, M.D., on Changing Concepts of Bipolar Disorder

Component Workshops

CW40. Advocacy: What Medical Students, Residents, and Early Career Psychiatrists Need to Know to Effect Change in the Political Process APA Assembly Committee of Area Member-in-Training Representatives; Co-Chairs: Jose Vito, M.D., Bob Kearley

CW41. One Psychiatrist's Boundary Violation May Be Another's Area of Work APA Assembly Allied Organization Liaisons; Chair: Lee Combrinck-Graham, M.D.

CW42. Grassroots in Action: District Branch Initiatives and APA Grant Funding Unite in Making a Difference APA Council on Member and District Branch Relations; Co-Chairs: Nioaka N. Campbell, M.D., Jeffrey S. Akman, M.D.

CW43. Foster Care: Are We Doing Our Best for the Children? APA Committee on Family Violence and Abuse; Chair: Gail Robinson, M.D.

CW44. Preventing Incarceration of the Mentally Ill: The Role of Psychiatry APA Assembly Allied Organization Liaisons; Chair: Steven K. Hoge, M.D.

CW45. CPT Coding and Documentation Update APA Committee on RBRVS, Codes, and Reimbursements; Co-Chairs: Ronald M. Burd, M.D., David K. Nace, M.D.

CW46. Psychiatric Services in Jails and Prisons: It's Time to Revise the APA Guidelines! APA Caucus of Psychiatrists Working in Correctional Settings; Chair: Henry C. Weinstein, M.D.

CW47. Why Business Needs Psychiatry and Why Psychiatry Needs Business: Lessons Learned From the CABR Model APA Committee on APA/Business Relationships; Chair: Alan M. Langlieb, M.D.

CW48. New APA Practice Guidelines: MDD and Bipolar Disorder APA Steering Committee on Practice Guidelines; Chair: John S. McIntyre, M.D.

CW49. Mental Health of Latinas: Changing Roles and Needs APA Committee of Hispanic Psychiatrists; Chair: Andres J. Pumariega, M.D.

Issue Workshops

IW45. Training for All Psychiatric Residents in Research and Scholarly Activity Co-Chairs: Milton Kramer, M.D., Michele Pato, M.D.

IW46. Infertility: What to Expect When You Are Not Expecting Co-Chairs: Joyce A. Spurgeon, M.D., Julianne Flynn, M.D.

IW47. Creating a Buprenorphine Wraparound Program in Your Community: Lessons Learned and What Works Chair: Jennifer L. Michaels, M.D.

IW48. Leadership in Psychiatry Co-Chairs: Julian Beezhold, M.D., Victor J. Buwalda, M.D.

IW49. Using Interpersonal Psychotherapy With Geriatric Patients Co-Chairs: Mark D. Miller, M.D., Gregory A. Hinrichsen, Ph.D.

IW50. Cognitive Therapy for Psychosis in Practice by Psychiatrists: Basic Techniques Chair: Shanaya Rathod, M.D.

IW51. Cognitive Therapy for Personality Disorders Chair: Judith S. Beck, Ph.D.

IW52. Phantoms of the Mind: The Role of Narcissism in Therapist Boundary Crossing Chair: Howard E. Book, M.D.

IW53. The Air Force Suicide Prevention Program: A Community and Organizational Approach to Prevention Chair: Steven E. Pflanz, M.D.

IW54. Teaching Residents in Consultation-Liaison Service to Recognize and Manage Countertransference Co-Chairs: Damir Huremovic, M.D., Nyapati R. Rao, M.D.

IW55. Quality Improvement Intervention for Depression in Primary Care National Institute of Mental Health; Chair: Agnes E. Rupp, Ph.D.

IW56. Forgiveness and Individual Psychotherapy: To Err Is Human, To Forgive Divine, or Is It? Chair: Janet L. Lewis, M.D.

IW57. Katrina's Long-Term Impact on Mental Health and Education Co-Chairs: Phebe M. Tucker, M.D., Harold M. Ginzburg, M.D.

IW58. Making the Most of Your Chief Year: Chief Residents' Forum, Part 1 Co-Chairs: Amy W. Poon, M.D., Carolyn I. Rodriguez, M.D.

IW59. Delivering Psychiatric Aid to Iraq: How Can American Psychiatrists Help in a Conflict Zone? Chair: Amir Afkhami, M.D.

IW60. The Physician as Patient: How Can We Help? Co-Chairs: Michael F. Myers, M.D., Glen O. Gabbard, M.D.

IW61. Psychiatry in Asia: Problems, Priorities, and Solutions Co-Chairs: Pedro Ruiz, M.D., Bruce S. Singh, Ph.D.
 

9 a.m.-Noon

Media Workshops

MP5. Michael Moore's "Sicko" Chair: Steven S. Sharfstein, M.D.

MP6. "Red Without Blue": A Film About Gay and Transgender Identical Twins American Academy of Child and Adolescent Psychiatry; Co-Chairs: Richard R. Pleak, M.D., Edgardo J. Menvielle, M.D.

MP7. "Shame and Silence": Understanding the Stigma of Mental Illness in Asian Americans Co-Chairs: Francis G. Lu, M.D., Elizabeth J. Kramer, S.M.

Symposia

S50. Advances in Early Detection, Treatment, and Prevention of Psychosis: Findings From the North American Prodrome Longitudinal Study

1. Predicting Psychosis Onset in Youth at High Clinical Risk: The Effects of Prodromal Symptoms, Neurocognition, and Family History Larry J. Seidman, Ph.D.
   
2. Risk of Mania in Persons at Heightened Clinical Risk for Psychosis Diana O. Perkins, M.D.
   
3. Cannabis Misuse and Risk for Psychosis in a Prodromal Sample Kristin S. Cadenhead, M.D.
   
4. The Relation of Antipsychotics and SSRIs With Baseline Symptoms and Symptom Progression in Prodromal Subjects: A Naturalistic Study Elaine Walker, Ph.D.
   
5. Psychosocial Treatments for the Psychosis Prodrome Jean M. Addington, Ph.D.
   
6. Should the Psychosis Prodrome Be Included in DSM-V? Scott W. Woods, M.D.
   

S51. Treating PTSD in a Violent World

1. Prevalence and Treatment of PTSD Charles R. Marmar, M.D.
   
2. Developing and Implementing PTSD Interventions in Real-World Settings Douglas F. Zatzick, M.D.
   
3. Cutting-Edge Treatment and Prevention Research Barbara Rothbaum, Ph.D.
   
4. Treatment and Prevention Research, Part 2: The Jerusalem Trauma Outreach and Early Prevention Study Arieh Y. Shalev, M.D.
   
5. Integrating Bio-Psycho-Social Factors Mediating Risk and Resiliency in PTSD Kerry Ressler, M.D.
    
   

9 a.m.-4 p.m.

CME Courses 84-89
 

10 a.m.-3 p.m.

Exhibits Open (last day)

APA Member Center Open (last day)

Publishers' Bookfair Open (last day)
 

11 a.m.-12:30 p.m.

Advances in Medicine

AM03. Obesity Julio Licinio, M.D.

Component Workshops

CW51. Psychiatric Aspects of Bariatric Surgery APA Caucus on Eating Disorders; Co-Chairs: Daniel I. Bober, D.O., Jodi E. Star, M.D.

CW52. One in a Million? Safety of Trainees in the Psychiatric Setting APA/GlaxoSmithKline Fellows; Co-Chairs: Umee A. Davae, D.O., Han-chun Liang, M.D.

CW53. Mental Health Effects of Disasters Among Ethnic Minority Elderly APA Committee on Ethnic Minority Elderly; Co-Chairs: Maria Llorente, M.D., Iqbal Ahmed, M.D.

CW54. Hot Issues in Psychiatry and Law APA Council on Psychiatry and Law; Co-Chairs: Paul S. Appelbaum, M.D., Steven K. Hoge, M.D.

Issue Workshops

IW62. (Hu)manualized Cognitive-Behavior Therapy With Children: Innovation and Improvisation in Treatment Chair: Robert D. Friedberg, Ph.D.

IW63. Integrating Psychiatry and Primary Care: A Rational Response to Continuing Mental Health Needs Following Hurricane Katrina Co-Chairs: Julia Z. Frank, M.D., Catherine S. May, M.D.

IW64. What Time Does Not Heal: Achieving Functional Recovery in Psychiatric Illness Co-Chairs: Marcia Scott, M.D., Paul Pendler, Psy.D.

IW65. Elvin Semrad's Interviewing Fundamentals for High-Pressure Clinical, Forensic, and Educational Contexts Chair: Robindra K. Paul, M.D.

IW66. Transition-Age Youth: An Overview on Psychological Development, Service Delivery, and Treatment Models Chair: Brooke A. Goldner, M.D.

IW67. The Portrayal of Psychiatry in Recent American Film Chair: Steven E. Pflanz, M.D.

IW68. Partnerships in the Americas: Update From the World Psychiatric Association American Psychiatric Association and the World Psychiatric Association; Co-Chairs: Michelle B. Riba, M.D., Lawrence Hartmann, M.D.

IW69. Making the Most of Your Chief Year: Chief Residents' Forum, Part 2 Co-Chairs: Amy W. Poon, M.D., Carolyn I. Rodriguez, M.D.

IW70. Navigating Terrorism and Its Relation to Mental Health: Middle East Perspective Co-Chairs: Mostafa K. Ismail, M.D., Zeinab Bishry, M.D.

IW71. Psychiatrists Who Have Been in Treatment: Part 2 Co-Chairs: Michael F. Myers, M.D., Leah J. Dickstein, M.D.

IW72. Emerging Trends in Drug Abuse: Monitoring to Stay Ahead of the Curve National Institute on Drug Abuse; Chair: Timothy P. Condon, Ph.D.

Scientific and Clinical Reports Session 18. Conversion, Somatization, and Chronic Fatigue

51. Demographic, Clinical, and Treatment Outcome Profiles in 71 Consecutive, Prospectively Studied Patients With Conversion Disorder (CD) Patricia Rosebush, M.D.

52. Somatization Increases Role Impairment and Disability Independent of Psychiatric and Medical Comorbidity Arthur J. Barsky, M.D.

53. The Comparative Epidemiology of Chronic Fatigue Between Brazilian and British Primary Care: Prevalence, Reporting, Recognition, and Labeling Hyong Cho, M.D.

Session 19. Managing Behavior in Patients and Psychiatrists

54. First Mailed Educational Intervention to Physicians Reduced Pharmacy, Hospital, and Outpatient Costs Harold Carmel, M.D.

55. Clinical Trial Reports in Psychiatry Before and After the CONSORT Statement Changsu Han, M.D.

56. Attachment, Contemporary Interpersonal Theory, and IPT: An Integration of Theoretical, Clinical, and Empirical Perspectives Paula Ravitz, M.D.

Session 20. Side Effects of Psychopharmacological Treatment

57. Long-Term Follow-Up of Patients With Major Depressive Disorder: Changes in Symptoms, Treatment, and Side Effects John Goethe, M.D.

58. Antipsychotic-Induced Extrapyramidal Side Effects in Bipolar Disorder and Schizophrenia Keming Gao, M.D.

59. Identification and Attribution of Side Effects of Antidepressants by Self Report and Psychiatrist Interview Rajnish Mago, M.D.

Session 21. Biological Psychiatry

60. Normalization of Immune Cell Imbalance After Pharmacological Treatments of Patients Suffering From Obsessive-Compulsive Disorder Donatella Marazziti, M.D.

61. Ventral Capsular/Ventral Striatal Gamma Capsulotomy for Obsessive-Compulsive Disorder: First Results of a Double-Blind, Randomized Controlled Trial Antonio Lopes, M.D.

62. Alterations of the Dopamine Transporter in Lymphocytes of Patients With Different Psychotic Disorders Giorgio Consoli, M.D.

Session 22. Social and Community Psychiatry

63. Treating Obesity: Interventions for Improving Body Mass Index and Increasing Fitness in an Inner-City Hispanic and African-American SPMI Population Joanne Caring, M.D.

64. FACT, A Dutch Version of ACT (Assertive Community Treatment) J. Remmers van Veldhuizen, M.D.

65. Psychiatric Housing: Correlates of Community Interaction Allison Zippay, Ph.D.

Session 23. Diagnosis

66. Threats to Validity in Causality Research Using Psychiatric Diagnoses Stephen Shanfield, M.D.

67. Is Bipolar Disorder Overdiagnosed? Mark Zimmerman, M.D.

68. What Can We Learn From Valid Diagnoses? Roger Peele, M.D.

Session 24. Treatment Decisions and Outcome in Depression

69. Disease Management for Patients With Difficult-to-Treat Depression Gabor Keitner, M.D.

70. Evidence-Based Medicine and Outcome: Three-Month Follow-Up of Inpatients With MDD Bonnie Szarek, R.N.

71. A Clinically Useful Depression Outcome Scale Mark Zimmerman, M.D.

Session 25. Studies in the Course of Schizophrenia

72. Separable Developmental Trajectories in Schizophrenia From Womb to Grave: Results From the Northern Finland 1966 Birth Cohort Matti Isohanni, Ph.D.

73. Predicting Schizophrenia Spectrum Disorders With Psychological Scales: The Northern Finland 1966 Birth Cohort Jouko Miettunen, Ph.D.

74. Recovery From Schizophrenia: A Meta-Analysis Erika Lauronen, B. Med.

Session 26. Psychopathology and Psychobiology of Borderline Personality

75. Trauma and Psychopathology in Patients With Borderline Personality Disorder and Their Sisters Joel Paris, M.D.

76. Specificity of Glutamatergic Neurotransmission and Borderline Personality Disorder Bernadette Grosjean, M.D.

77. Pain in Borderline Personality Disorder: Examining the Role of NMDA Neurotransmission Jonathan Still, M.D.
 

11 a.m.-12:30 p.m.

Small Interactive Session

15. Jerome Smoller, M.D., on Psychiatric Genetics: Applications in Clinical Practice (Meet the Author)
 

Noon-1:30 p.m.

Forums

7. APA and APAL: Building Bridges, Finding Routes Chair: Renato Alarçon, M.D.

8. Managing the Effects of Combat Trauma: The Evolving Practice at Walter Reed Army Medical Center Chair: Harold Wain, M.D.
 

Noon-2 p.m.

New Research Poster Session 6
 

1 p.m.-5 p.m.

CME Courses 90-93
 

2 p.m.-5 p.m.

Presidential Symposia

3. The Myth of the Med Check Chair: Glen Gabbard, M.D.

4. Advocating With One Voice for Mental Health Care in the U.S. and U.K. Chair: Sheila Hollins, M.D.

Symposia

S52. An Interstate Comparison of Exclusions to Involuntary Civil Commitment Laws: Has a Bioethics Success Come Undone?

1. Legal Issues Raised by Exclusions in Civil Commitment Statutes Karoline K. Adler, Esq.
   
2. Psychiatric Limitations of the Mental Retardation Exclusion Fayez A. El Gabalawi, M.D.
   
3. Ethical and Conceptual Issues Claire L. Pouncey, M.D.
   
4. Policy Issues Lawrence A. Real, M.D.
   

S53. Dimensional Models for Personality Disorder Assessment

1. Prevalence and Persistence of Criteria for Schizotypal, Borderline, Avoidant, and Obsessive-Compulsive Personality Disorders at Six-Year Follow-Up Emily B. Ansell, Ph.D.
   
2. Six-Year Stability of DSM-IV Schizotypal, Borderline, Avoidant, and Obsessive-Compulsive Personality Disorder Constructs Charles A. Sanislow, Ph.D.
   
3. Persistence of Personality Disorder Psychopathology and Functional Impairment Over Time Andrew E. Skodol, M.D.
   
4. Traitedness as an Indicator of Incremental Validity in the Five-Factor Model of PD Assessment Megan B. Warner, Ph.D.
   
5. Predictors of Change in Personality Traits Sara E. Lowmaster, M.S.
   

S54. Gene-Environment-Developmental Interactions: Implications for Psychiatric and Addictive Disorders

1. MAOA by Maltreatment Gene x Environment Interaction and Children's Behavior Problems Julia Kim-Cohen, Ph.D.
   
2. Role of MEF2 in Cocaine-Induced Synaptic and Behavioral Plasticity Christopher W. Cowan, Ph.D.
   
3. Epigenetic Influence of the Early Environment Frances A. Champagne, Ph.D.
   

S55. Stalking Interventions and Treatment

1. Stalking: Overview and Treatment of Victims Gail E. Robinson, M.D.
   
2. Stalking Interventions and Treatment Karen M. Abrams, M.D.
   
3. Treatment of Stalkers: Challenging the Intervention Dilemma Werner Tschan, M.D.
   
4. Threat Management by Multi-Agency Joint Cooperation Totti Karpela
   

S56. Update on NMS With Case Reviews

1. The Pathophysiology and Treatment of NMS: Current Perspectives Ronald J. Gurrera, M.D.
   
2. Complications of NMS Dora D. Kohen, M.D.
   
3. A Naturalistic, Prospective Study of 53 Patients With NMS Secondary to Typical and Atypical Antipsychotic Drugs Patricia Rosebush, M.D.
   

S57. Demoralization and Psychotherapy: Research Advances and Clinical Implications

1. Demoralization and the Course of PTSD: Two Years After Hurricane Mitch Robert Kohn, M.D.
   
2. Psychotherapy for Demoralization in the Physically Ill David M. Clarke, M.B.
   
3. Psychotherapeutic Interventions for Mobilizing Hope in Demoralized Patients James L. Griffith, M.D.
   

S58. Drug Abuse, HIV, HCV, and the Brain

1. Methamphetamine and HIV: CNS Effects Igor Grant, M.D.
   
2. Pathogenesis of Hepatitis C Virus Coinfection in the Brains of Patients Infected With HIV Eliezer Masliah, M.D.
   
3. Neurologic and Psychiatric Complications of ART and Drug Interactions Glenn J. Treisman, M.D.
   
4. Neuroeconomics: New Approaches to Risky Decision Making Gregory S. Berns, M.D.
   
5. A New Basic Approach to Understand Dysregulation of Reward Systems in Substance Use Martin P. Paulus, M.D.
   

S59. Treatment of Adolescent Depression: Results From Recent Trials and Implications for Practice

1. The Treatment for Adolescents With Depression Study (TADS): Implications for Practice John S. March, M.D.
   
2. The Treatment of SSRI-Resistant Depression in Adolescents (TORDIA) David A. Brent, M.D.
   
3. Exporting Evidence-Based Depression Treatment to Primary Care Clinics: Impact on Adolescent Depression Outcomes Joan R. Asarnow, Ph.D.
   
4. Delivering Evidence-Based Psychotherapy for Teen Depression in Primary Care, With and Without Pharmacotherapy: Approaches, Issues, and Outcomes Greg Clarke, Ph.D.
   

S60. Research Update: Current Prospects for Enhanced Treatments for Schizophrenia, Mood Disorders, Anxiety Disorders, and Substance Abuse

1. Developing Improved Therapeutics for Refractory Mood Disorders Carlos Zarate, M.D.
   
2. Genomic Approaches to the Treatment of Alcoholism Charles O'Brien, M.D.
   
3. Translational Studies in Anxiety Disorders: New Insights and Treatments Kerry Ressler, M.D.
   
4. Treatments for Schizophrenia: Current Limitations and Future Promises Jeffrey Lieberman, M.D.
   

S61. Cardiometabolic Risk During Treatment With Antipsychotic Medications

1. Antipsychotic Medications Metabolic and Cardiovascular Risk in Older Patients Dilip V. Jeste, M.D.
   
2. Treatment Strategies to Prevent Weight Gain, Produce Weight Loss, or Improve Insulin Sensitivity in Response to Psychiatric Medications Tony A. Cohn, M.B.
   
3. Clinician-Level Approaches Michael J. Sernyak, M.D.
   

S62. Mood Disorders Through the Life Cycle in France and the United States: "Vive la Difference!"

1. How Well Do We Know How to Recognize and Address Infant and Early Childhood Depression? Gisèle Apter-Danon, M.D.
   
2. Functional Neuroimaging Findings in Youth With Bipolar Disorder Ellen Leibenluft, M.D.
   
3. From the French Paradox to the French Program Against Depression Frederic Rouillon, M.D.
   
4. STAR*D: What Are the Take-Home Messages for Clinicians? A. John Rush, M.D.
   
5. Treating Mental Disorders of the Elderly in France: A Daring Fight or a Lost Cause? Thierry Gallarda, M.D.
   
6. Reducing Suicidal Ideation and Depression in Older Primary Care Patients: Two-Year Outcomes of the Prospect Study George S. Alexopoulos, M.D.
   

S63. Stop It: You're Making Me Sick Revisited: Landmarks in the Struggle to Normalize Lesbian and Gay Lives

1. How It All Started Franklin Kameny, Ph.D.
   
2. From Disorder to Dystonia: DSM-II to DSM-III Richard C. Pillard, M.D.
   
3. Strike While the Iron Is Hot! Science and Social Forces and Ego-Dystonic Homosexuality Robert P. Cabaj, M.D.
   
4. Sexual Orientation and Psychiatric Diagnosis: Current Issues in DSM-IV and Moving Toward DSM-V Benjamin H. McCommon, M.D.
   
5. Eliminating Anti-Gay Diagnoses in WHO's International Classification of Disorders (ICD) Gene A. Nakajima, M.D.
   

S64. Depression Among Emergency Department Patients in Latin-American Countries

1. Underlying Differences Between Depressed and Nondepressed Patients in Emergency Departments Roxana B. Galeno, M.D.
   
2. Depression and Medical Comorbidity in Emergency Departments in Latin America Ricardo Secin, M.D.
   
3. Challenges in the Diagnosis of Depression in Emergency Departments Arturo P. Grau, M.D.
   
4. The Burden of Comorbid Depression in Emergency Departments in Latin America Carlos Sanchez-Russi, Ph.D.
   

S65. Cognitive Dysfunction in Bipolar Disorder

1. A Clinician-Friendly Approach to Neurocognitive Assessment Katherine E. Burdick, Ph.D.
   
2. Neurocognitive Deficits Across Illness Phases in Bipolar Disorder Eduard Vieta, M.D.
   
3. Neurocognition as an Endophenotype in Bipolar Disorder David Glahn, Ph.D.
   
4. Beneficial and Adverse Cognitive Effects of Psychotropic Medications for Bipolar Disorder Joseph F. Goldberg, M.D.
   
5. Attention and Cognitive Dysfunction in Pediatric Bipolar Disorder Paula Shear, Ph.D.
   

S66. The Scientific Basis of Interpersonal Dysfunction in Borderline Personality Disorder

1. The Intrapsychic and Neurocognitive Basis of Interpersonal Dysfunction in BPD Patients John F. Clarkin, Ph.D.
   
2. A Prospective Longitudinal View of Genetic Vulnerability and Quality of Early Care as Contributors to Borderline Features Karlen Lyons-Ruth, Ph.D.
   
3. Interpersonal Stress Reactivity, Attachment, and Borderline Personality Disorder Lois W. Choi-Kain, M.D.
   
4. Can a Deficit in Mentalization Explain the Interpersonal Dysfunction in BPD? Peter Fonagy, Ph.D.
   

S67. DSM-V: Philosophical and Clinical Considerations

1. Vice in DSM-IV Diagnostic Criteria John Sadler, M.D.
   
2. Are Personality Disorders Infected With Moral Norms? Considerations From Virtue Theory Peter Zachar, Ph.D.
   
3. Are Relational Problems Mental Disorders, and Should They Be in DSM-V? Christian D. Perring, Ph.D.
   
4. What Is Moody? What Is Bipolar? S. Nassir Ghaemi, M.D.
   

S68. Pharmacotherapy of Unipolar Psychotic Depression: Results From the National Institute of Mental Health STOP-PD Trial

1. Challenges in the Diagnosis and Treatment of Psychotic Depression Anthony J. Rothschild, M.D.
   
2. Design Issues Related to Recruiting, Protecting, and Retaining Patients With Psychotic Depression in a Randomized, Controlled Pharmacotherapy Trial Alastair J. Flint, M.B.
   
3. Neuropsychological Functioning in Patients With Psychotic Major Depression Ellen M. Whyte, M.D.
   
4. The Efficacy of Combination Pharmacotherapy Compared to Atypical Antipsychotic Monotherapy for Major Depression With Psychotic Features Barnett S. Meyers, M.D.
   
5. Tolerability of Intensive Pharmacotherapy and Predictors of Attrition Benoit H. Mulsant, M.D.
   

S69. Privacy and Fraud Policies and Electronic Health Records

1. National Health IT Agenda: Privacy and Security Robert Kolodner, M.D.
   
2. Psychiatric Health Records as Sensitive Information Mark A. Rothstein, J.D.
   
3. Model Anti-Fraud Requirements for Electronic Health Records Colleen McCue, Ph.D.
   
4. What the Certification Commission for Health Information Technology Might Do Zebulon Taintor, M.D.
   
5. Privacy and Electronic Health Records Deborah C. Peel, M.D.
   

S70. Does Peer Support Have a Role in Psychiatry?

1. Foundations of Peer Support Larry Davidson, Ph.D.
   
2. Peer Outreach as an Alternative to Outpatient Commitment Dave Sells, Ph.D.
   
3. The Recovery Mentor Study Martha Lawless
   
4. Partners in Planning: Person-Centered Care as a Pathway to Community Life Chyrell Bellamy, M.S.W.
   

S71. Features of Autism in Adulthood

1. An Analysis of the Concept of Empathy and Its Relevance for the Understanding of Autism Gerrit G. Glas, M.D.
   
2. Management of Intellectually Able Adults With Autism Spectrum Disorders Bram B. Sizoo, M.D.
   
3. Comorbidity Issues in Autism Spectrum Disorders in Adults Patricia J. van Wijngaarden-Cremers, M.D.
   
4. Assessment and Diagnosis of Autism Spectrum Disorders in Adults Rutger Jan van der Gaag, M.D.
   

S72. Transforming the Provision of Mental Health Services: The CalMEND Project

1. CalMEND: An Initiative to Rationalize Care for Mentally Ill Persons Across State Systems in California Barry E. Handon, M.D.
   
2. Devising a Durable Treatment Plan: Who Decides? Thu A. Bui, M.D.
   
3. Incorporating Both Family Support and Evidence-Based Practices in Treatment for Children Penelope K. Knapp, M.D.
   
4. Identifying Antipsychotic Polypharmacy and the Collaborative Performance Improvement Project Douglas Del Paggio, Pharm.D.
   
5. Antipsychotic Treatment Decisions: Who Determines Recovery of Function? Pauline Chan, R.Ph.
   

S73. Affective Instability in Borderline Personality Disorder

1. Stability and Variability of Affective Experience and Interpersonal Behavior in Borderline Personality Disorder Jennifer Russell, Ph.D.
   
2. Clarifying the Nature of Affective Instability in Borderline Personality Disorder Paul Links, M.D.
   
3. Neural Correlates of Affective Instability in Borderline Personality Disorder Harold Koenigsberg, M.D.
   
4. The Interface Between BPD and Bipolar Disorder Joel Paris, M.D.
   

S74. Cognitive Effects of Second-Generation Antipsychotics: Experiences From First-Episode Studies

1. Cognitive Change With Treatment: Real or Practice Effects? Terry E. Goldberg, Ph.D.
   
2. Using Translational Cognitive Neuroscience Paradigms to Explore the Effects of Second-Generation Agents John A. Sweeney, Ph.D.
   
3. The Cognitive Effects of Risperidone, Olanzapine, and Quetiapine in Patients With First-Episode Psychosis Richard S. Keefe, Ph.D.
   
4. Multidimensional Outcomes of Treatment of First-Episode Schizophrenia With Second-Generation Antipsychotics Delbert Robinson, M.D.
   

S75. Mood Disorders and Medical Comorbidity, Causes, and Consequences

1. Mood Disorders and Medical Comorbidity, Causes, and Consequences Claus H. Sørensen, M.D.
   
2. Post-Stroke Depression Grethe Andersen, M.D.
   
3. Can Treatment of Depression Reduce Cardiac Risk? Steven P. Roose, M.D.
   
4. Depression and Diabetes: Current Challenges and Future Directions Dominique L. Musselman, M.D.
    
   

3 p.m.-5 p.m.

New Research Poster Session 7
 

7 p.m.-10 p.m.

Industry-Supported Symposia

Email this article to a Colleague Similar articles in this journal Alert me to new issues of the journal Download to citation manager

Get information about faster international access.

Privacy Policy

Copyright © 2008 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us